Alcoholic liver disease
Therapeutic area
Endocrinology
Rare disease
No
- Definition
- A disorder caused by damage to the liver parenchyma due to alcohol consumption. It may present with an acute onset or follow a chronic course, leading to cirrhosis.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Alcoholic liver disease
- Therapeutic area
- Endocrinology
- alcoholic liver disease
- alcoholic liver disease
- alcoholic liver diseases
- alcoholic liver damage
- liver disease, alcoholic
- Severity
- Severe
- Endocrinology
- Gastroenterology
- MONDO ID
- MONDO:0043693
- Parent condition
- MONDO:0005154
Related records
Broader conditions (12)
- Alcohol-induced disorders
- Alcohol-related disorders
- Digestive system disorder
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Endocrine system disorder
- Hepatobiliary disorder
- Human disease
- Liver disorder
- Psychiatric disorder
- Substance-related disorder
Narrower conditions (3)
- Alcoholic fatty liver disease
- Alcoholic hepatitis
- Alcoholic liver cirrhosis
Trials (73)
- A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease
- A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)
- A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit
- Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial
- Alcohol, Gut Leakiness, & Liver Disease
- Alcoholic Liver Disease and the Gut Microbiome
- Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease
- Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)
- Biomarkers for the Prognosis of Decompensated Alcoholic Liver Disease
- BRIDGE Device for Post-operative Pain Control
- Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency
- CM for Patients With ALD After Liver Transplant
- Cognitive Function of Alcoholic Compensated Liver Cirrhosis
- Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation
- Comparison of ALD, NASH, and Healthy Control Patients
- Double-blind Randomized Controlled Trial in Severe Alcoholic Hepatitis
- DUR-928 in Patients With Alcoholic Hepatitis
- Early Detection of Alcoholic Liver Disease
- Effect of Candesartan in Alcoholic Liver Fibrosis
Drugs in development (8)
- Amoxicillin Phase 3
- Aspirin Early phase 1
- Candesartan Phase 1
- Guselkumab Phase 1
- Larsucosterol Phase 1
- Larsucosterol sodium Phase 1
- Pemvidutide Phase 2
- Prednisolone Phase 3